Hematologic Disorders
📧 Sign up to get email alerts when something new happens for Hematologic Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Efficacy and Safety of Lusutrombopag After Allogeneic Hematopoietic Stem Cell Transplantation [NA]
A clinical trial is evaluating the efficacy and safety of lusutrombopag in patients with hematologic disorders after allogeneic hematopoieti…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases [Phase 1, Phase 2]
Clinical trial update for a conditioning regimen using Campath, fludarabine, and melphalan for non-malignant diseases; currently recruiting …
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: CD62L Depleted Donor Lymphocyte Infusion With T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation [Phase 2]
Phase 2 clinical trial evaluating CD62L-depleted donor lymphocyte infusion with T cell-depleted haploidentical hematopoietic stem cell trans…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC) [NA]
ClinicalTrials.gov entry for a second or greater allogeneic hematopoietic stem cell transplant using reduced intensity conditioning, current…
-
CLINICAL_TRIALS research · 2025-06-17Clinical Trial Update: Visual and Auditory Distraction for the Relief of Pain and Anxiety [NA]
Update on a clinical trial assessing visual and auditory distraction to relieve pain and anxiety during bone marrow aspiration.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.